Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma

Frederick W F Thielen, R.J. Heine, Sibren van den Berg, RMT ten Ham, Carin A Uyl-de Groot

Research output: Contribution to journal › Article › Academic › peer-review

2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science